Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-07-17 00:00:00 ET · period of report 2024-07-16 · accession 0001649094-24-000036 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-17 | 2024-07-16 | PCVX | Cowan Elvia | SVP, Fin | M - OptEx | $25.92 | +5,000 | 17.7K | +39% | +$129.6K |
| D | 2024-07-17 | 2024-07-16 | PCVX | Cowan Elvia | SVP, Fin | S - Sale+OE | $85.00 | -5,000 | 12.7K | -28% | -$425.0K |
| D | 2024-07-17 | 2024-07-16 | PCVX | Cowan Elvia | SVP, Fin | M - OptEx | $0.00 | -5,000 | 119.0K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-16 | M | A | 5,000 | $25.92 | 17,723 | D | — | — | |
| 2 | Common | Common Stock | 2024-07-16 | S | D | 5,000 | $85.00 | 12,723 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-07-16 | M | D | 5,000 | $0.00 | 119,000 | D | $25.92 · — to 2032-08-08 | 5,000 Common Stock | (F2) 1/4 of the shares subject to the option vested on July 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |